相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Gaucher iPSC-Derived Macrophages Produce Elevated Levels of Inflammatory Mediators and Serve as a New Platform for Therapeutic Development
Leelamma M. Panicker et al.
STEM CELLS (2014)
Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease
M. Reed et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease
Cecile Braudeau et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease
Juan M. Mucci et al.
GENE (2013)
Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment
Neal J. Weinreb et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy
Fabrice Camou et al.
BLOOD CELLS MOLECULES AND DISEASES (2012)
Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α
Juan M. Mucci et al.
GENE (2012)
Osteocyte RANKL: New insights into the control of bone remodeling
Jinhu Xiong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease
Manoj Kumar Pandey et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Gaucher disease gene GBA functions in immune regulation
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bone Marrow Microenvironment in an In Vitro Model of Gaucher Disease: Consequences of Glucocerebrosidase Deficiency
Severine Lecourt et al.
STEM CELLS AND DEVELOPMENT (2012)
Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adults
Pramod K. Mistry et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction
Deborah Elstein et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
Radiological aspects of Gaucher disease
Robert Katz et al.
SKELETAL RADIOLOGY (2011)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase
Ilaria Roato et al.
PLOS ONE (2010)
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
Tamar H. Taddei et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts
Teun J. de Vries et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Estrogen deficiency, T cells and bone loss
Roberto Pacifici
CELLULAR IMMUNOLOGY (2008)
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study
K. B. Sims et al.
CLINICAL GENETICS (2008)
Eight-Year Clinical Outcomes of Long-Term Enzyme Replacement Therapy for 884 Children With Gaucher Disease Type 1
Hans Andersson et al.
PEDIATRICS (2008)
Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease
Makoto Yoshino et al.
PEDIATRICS INTERNATIONAL (2007)
Increased plasma macrophage inflammatory protein (MIP)-1α and MIP-1β levels in type 1 Gaucher disease
Marielle J. van Breemen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
The stem cell niches in bone
T Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Phenotype variations in Gaucher disease
P Mistry
REVUE DE MEDECINE INTERNE (2006)
Interplay between interferon and other cytokine systems in bone metabolism
H Takayanagi et al.
IMMUNOLOGICAL REVIEWS (2005)
Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model
A Balreira et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Survey of hematological aspects of Gaucher disease
A Zimran et al.
HEMATOLOGY (2005)
Expression of membrane-bound and soluble receptor activator of NF-κB ligand (RANKL) in human T cells
F Kanamaru et al.
IMMUNOLOGY LETTERS (2004)
Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy
M Itzchaki et al.
ACTA ORTHOPAEDICA SCANDINAVICA (2004)
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
RG Boot et al.
BLOOD (2004)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Skeletal aspects of Gaucher disease: a review
RJ Wenstrup et al.
BRITISH JOURNAL OF RADIOLOGY (2002)
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand:: Modulation of the expression by osteotropic factors and cytokines
T Nakashima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The immune system - First of two parts
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
